[Myths and evidence on the use of botulinum toxin: neuropharmacology and dystonia].

CONCLUSION: This review does not pretend to be a guide, but rather a tool for continuous training of residents and specialists in neurology, about different specific areas of the management of BTA. PMID: 29480513 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29480513?dopt=Abstract

Source: Revista de Neurologia - February 27, 2018 Category: Neurology Authors: Garcia-Ruiz PJ, Sanz-Cartagena P, Martinez-Castrillo JC, Ares-Pensado B, Aviles-Olmos I, Blazquez-Estrada M, Fanjul-Arbos S, Garcia-Caldentey J, Gazulla J, Gutierrez-Garcia J, Huete-Anton B, Lucas-Rodenas C, Luquin MR, Martinez-Torres I, Medialdea-Natera Tags: Rev Neurol Source Type: research